Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Canon Medical, Quidel.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ambu, ATTC, Biointellisense, Biomerica, Bio-Techne, Centogene, Clinical Laserthermia Systems, Dover, Em-tec, Llamasoft, MeMD, Myriad Genetics, Oxford Nanopore Technologies, Pacific Biosciences of California, Parallax Health Sciences, Qiagen, Rewalk Robotics, Startx, Tomi Environmental Solutions, Tabula Rasa Healthcare, Windgo.

BEIJING – One day after the U.S. began the first human trial of an mRNA vaccine candidate for COVID-19 on March 16, China said Tuesday evening that it had approved the first clinical trial of a vaccine candidate developed by domestic researchers.

The latest global regulatory news, changes and updates affecting biopharma, including: Astrazeneca, Boehringer Ingelheim, Janssen, Lilly, Merck.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alpine, Biohaven, Pharnext, Rhythm, Sage, Synairgen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Allergan, Astrazeneca, Arrowhead, Asklepios, Axim, BMS, Cannabics, Emergent, Ergomed, Eusa, Fujifilm, Geovax, Horama, Ibio, Ideaya, IMV, Lumos, Mateon, Newlink, Oxford Biomedica, Pfizer, Vaxart, Versatope.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Addex, Enlivex, Graybug, Ideaya, Iveric, Sellas, Vivoryon.

Biopharmas raising money in public or private financings, including: Galapagos, IMV.